Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications

Synapse

Volumn 36, Issue 2, 2000, Pages 102-113

  Baumann, M H ^a,c   Ayestas, M A ^a   Dersch, C M ^a   Brockington, A ^a   Rice, K C ^b   Rothman, R B ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Addiction; Anorectics; Dopamine transporter; Drug dependence; In vivo microdialysis; Obesity; Serotonin transporter

Indexed keywords

CHLORPHENTERMINE; DOPAMINE; DOPAMINE TRANSPORTER; FENFLURAMINE; PHENTERMINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MICRODIALYSIS; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PRIORITY JOURNAL; RAT; SUBSTANCE ABUSE;

EID: 0034113934     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2396(200005)36:2<102::aid-syn3>3.0.co;2-%23     Document Type: Article

References (56)

1. Atkinson RL, Blank RC, Schumacher D, Dhurandhar NV, Ritch DL. 1997. Long-term drug treatment of obesity in a private practice setting. Obes Res 5:578-586.
2. Balcioglu A, Wurtman RJ. 1998. Effects of phentermine on striatal dopamine and serotonin release in conscious rats: in vivo microdialysis study. Int J Obes Relat Metab Disord 22:325-328.
3. Baumann MH, Rothman RB. 1998. Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans. Biol Psychiatry 44:578-591.
4. Baumann MH, Char GU, De Costa BR, Rice KC, Rothman RB. 1994. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J Pharmacol Exp Ther 271:1216-1222.
5. Benloucif S, Galloway MP. 1991. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1-8.
6. Berger UV, Gu XF, Azmitia EC. 1992. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215:153-160.
7. 125I]-RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36.
8. Brauer LH, Johanson CE, Schuster CR, Rothman RB, De Wit H. 1996. Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers. Neuropsychopharmacology 14:233-241.
9. Celada P, Artigas F. 1993. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn Schmiedebergs Arch Pharmacol 347:583-590.
10. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Schaff HV. 1997. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337:581-588.
11. Cox RH Jr, Maickel RP. 1972. Comparison of anorexigenic and behavioral potency of phenylethylamines. J Pharmacol Exp Ther 181: 1-9.
12. DiChiara G, Tanda G, Cadoni C, Acquas E, Bassero V, Carboni E. 1998. Homologies and differences in the activation of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretive framework of the mechanism of drug dependence. Adv Pharmacol 42:983-987.
13. Dingemanse J, Kneer J, Wallnofer A, Kettler R, Zurcher G, Koulu M, Korn A. 1996. Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline. Clin Neuropharmacol 19:399-414.
14. Donnelly M, Rapoport JL, Potter WZ, Oliver J, Keysor CS, Murphy DL. 1989. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings. Arch Gen Psychiatry 46:205-212.
15. Fischer JF, Cho AK. 1979. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203-209.
16. Glowa JR, Rice KC, Matecka D, Rothman RB. 1997. Phentermine/ fenfluramine decreases cocaine self-administration in rhesus monkeys. Neuroreport 8:1347-1351.
17. Gorelick DA. 1989. Serotonin uptake blockers and the treatment of alcoholism. In: Galanter M, editor. Recent developments in alcoholism. New York: Plenum. p 267-281.
18. Griffith JD, Jasinski DR, Pevnick JS. 1976. Chlorphentermine: absence of amphetamine-like profile in man [Abstract]. Clin Pharmacol Ther 19:107.
19. Griffiths RR, Brady JV, Snell JD. 1978. Relationship between anorectic and reinforcing properties of appetite suppressant drugs: implications for assessment of abuse liability. Biol Psychiatry 13:283-290.
20. Halladay AK, Fisher H, Wagner GC. 1998. Interaction of phentermine plus fenfluramine - neurochemical and neurotoxic effects. Neurotoxicology 19:177-183.
21. 3H] dopamine in rat brain tissue slices. Biochem Pharmacol 24:847-852.
22. Higgins GA, Tomkins DM, Fletcher PJ, Sellers EM. 1992. Effect of drugs influencing 5-HT function on ethanol drinking and feeding behavior in rats. Studies using a drinkomer system. Neurosci Biobehav Rev 16:535-552.
23. Hitzig P. 1993. Combined dopamine and serotonin agonists: a synergistic approach to alcoholism and other addictive behaviors. Maryland Med J 24:153-157.
24. Hoebel BG, Hernandez L, Schwartz DH, Mark GP, Hunter GA. 1989. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann NY Acad Sci 575:171-191.
25. Jacocks HM, Cox BM. 1992. Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine. J Pharmacol Exp Ther 262:356-364.
26. Kato T, Dong B, Ishii K, Kinemuchi H. 1986. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats. J Neurochem 46:1277-1282.
27. Kelland MD, Chiodo LA. 1996. Serotonergic modulation of midbrain dopamine systems. In: Ashby CR, editor. The modulation of dopamine neurotransmission by other neurotransmitters. Boca Raton, FL: CRC Press. p 87-122.
28. Kuczenski R, Segal DS. 1994. Neurochemistry of amphetamine. In: Cho AK, Segal DS, editors. Amphetamine and its analogs. San Diego: Academic Press. p 81-113.
29. Kuhar MJ, Pilotte NS. 1996. Neurochemical changes in cocaine withdrawal. Trends Pharmacol Sci 17:260-264.
30. Maher TJ, Ulus IH, Wurtman RJ. 1999. Phentermine and other monoamine oxidase inhibitors may increase plasma serotonin when given with fenfluramines. Lancet 353:38.
31. Matos FF, Rollema H, Basbaum AL. 1990. Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis. Brain Res 528:39-47.
32. Mirovsky Y, Yu Y-L, Wagner GC, Sekowski A, Goldberg M, Fisher H. 1995. Novel synergistic treatment of ethanol withdrawal seizures in rats with dopamine and serotonin agonists. Alcohol Clin Exp Res 19:160-163.
33. Papasava M, Singer G, Papasava CL. 1985. Phentermine self-administration in naïve free-feeding and food-deprived rats: a dose response study. Psychopharmacology 85:410-413.
34. Parsons LH, Justice JB Jr. 1993. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606:195-199.
35. Paxinos G, Watson C. 1982. The rat brain in stereotaxic coordinates. New York: Academic Press.
36. Rea WP, Rothman RB, Shippenberg TS. 1998. Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies. Synapse 30:107-111.
37. Rothman RB. 1999a. Is phentermine an inhibitor of monoamine oxidase? A critical appraisal [Letter]. Synapse 32:141-145.
38. Rothman RB. 1999b. Does phentermine inhibit monoamine oxidase? [Letter] Lancet 353:1362-1363.
39. 3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists. Life Sci 53:PL267-PL272.
40. Rothman RB, Lewis B, Dersch CM, Xu H, Radesca L, De Costa BR, Rice KC, Kilburn RB, Akunne HC, Pert A. 1993b. Identification of a GBR12935 homolog, LR1111, which is over 4000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14:34-39.
41. 125I]RTI-55. J Pharmacol Exp Ther 270:296-309.
42. Rothman RB, Gendron TM, Hitzig P. 1994b. Combined use of fenfluramine and phentermine in the treatment of cocaine addiction: a pilot case series. J Subst Abuse Treat 11:273-275.
43. Rothman RB, Ayestas M, Baumann MH. 1996. Phentermine pretreatment antagonizes the cocaine-induced rise in mesolimbic dopamine. Neuroreport 8:7-9.
44. Rothman RB, Elmer GI, Shippenberg TS, Rea W, Baumann MH. 1998. Phentermine and fenfluramine: preclinical studies in animal models of cocaine addiction. Ann NY Acad Sci 844:59-74.
45. Rowland NE, Carlton J. 1986. Neurobiology of the anorectic drug fenfluramine. Prog Neurobiol 27:13-62.
46. Rudnick G, Clark J. 1993. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144:249-263.
47. Scorza MC, Carrau C, Silveira R, Zapata-Torres G, Cassels BK, Reyes-Parada M. 1997. Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships. Biochem Pharmacol 54:1361-1369.
48. Shoaib M, Baumann MH, Rothman RB, Goldberg SR, Schindler CW. 1997. Behavioral and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats. Psychopharmacology 131:296-306.
49. Silverstone T. 1992. Appetite suppressants: a review. Drugs 43:820-836.
50. Sonders MS, Zhu SJ, Zahnhiser NR, Kavanaugh MP, Amara SG. 1997. Multiple ionic conductances of the human, dopamine transporter: actions of dopamine and psychostimulants. J Neurosci 17: 960-974.
51. Wayment H, Meiergerd SM, Schenk JO. 1998. Relationship between the catechol substrate binding site and amphetamine, cocaine, and mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro. J Neurochem 70:941-1949.
52. Weintraub M, Hasday JD, Mushlin AI, Lockwood DH. 1984. A doubleblind clinical trial in weight control: use of fenfluramine and phentermine alone and in combination. Arch Intern Med 144:1143-1148.
53. Weiss F, Hurd YL, Ungerstedt U, Markou A, Plotsky PM, Koob GF. 1992. Neurochemical correlates of cocaine and ethanol self-administration. Ann NY Acad Sci 654:220-241.
54. Wood DM, Emmett-Oglesby MW. 1998. Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine. Psychopharmacology 95:364-368.
55. Yu YL, Fisher H, Sekowski A, Wagner GC. 1997. Amphetamine and fenfluramine suppress ethanol intake in ethanol-dependent rats. Alcohol 14:45-48.
56. Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D. 1985. Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment. Arch Gen Psychiatry 42:969-973.